Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human Angiomotin Anticorps:
anti-Mouse (Murine) Angiomotin Anticorps:
anti-Rat (Rattus) Angiomotin Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal Angiomotin Primary Antibody pour DB - ABIN1881054
Heller, Adu-Gyamfi, Smith-Kinnaman, Babbey, Vora, Xue, Bittman, Stahelin, Wells: Amot recognizes a juxtanuclear endocytic recycling compartment via a novel lipid binding domain. dans The Journal of biological chemistry 2010
Show all 5 Pubmed References
Human Polyclonal Angiomotin Primary Antibody pour WB - ABIN531071
Chan, Lim, Chong, Pobbati, Huang, Hong: Hippo pathway-independent restriction of TAZ and YAP by angiomotin. dans The Journal of biological chemistry 2011
Show all 2 Pubmed References
Human Polyclonal Angiomotin Primary Antibody pour IF (p), IHC (p) - ABIN754873
Shimada, Abe, Kohno, Satohisa, Konno, Takahashi, Hatakeyama, Arimoto, Kakuki, Kaneko, Takano, Saito, Kojima: Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer. dans Scientific reports 2017
Amot and AmotL1 (Montrer AMOTL1 Anticorps) have similar effects on endothelial migration and tight junction formation in vitro. In vivo Amot appears to control the cell polarity and AmotL1 (Montrer AMOTL1 Anticorps) affects the stability of cell-cell junctions.
Thus AMOT is a direct substrate of Lats1 (Montrer LATS1 Anticorps)/2 mediating functions of the Hippo pathway in endothelial cell migration and angiogenesis.
knockdown of Amot reduced the number of filopodia of endoth (Montrer PDPN Anticorps)elial tip cells and severely impaired the migration of intersegmental vessels
Amot and AmotL1 (Montrer AMOTL2 Anticorps) have similar effects on endothelial migration and tight junction formation in vitro. In vivo Amot appears to control the cell polarity and AmotL1 (Montrer AMOTL2 Anticorps) affects the stability of cell-cell junctions.
Data indicate that Amot is crucial for the maintenance of nuclear YAP (Montrer YAP1 Anticorps) to promote renal epithelial and RCC (Montrer XRCC1 Anticorps) proliferation.
Decreased AMOT-p130 (Montrer RBL2 Anticorps) expression coupled with high nuclear YAP1 (Montrer YAP1 Anticorps) expression resulted in shorter overall survival and disease-free survival in patients with advanced gastric cancer.
Study focused on the methylation profile of the AMOT promoter CpG island during development, comparing it in circulating cord blood endothelial progenitor cells (ECFC) of cord blood from term versus preterm newborns. Findings highlight importance of pro-angiogenic AMOT gene methylation in ECFC, suggesting that epigenetic mechanisms may control the regulation of angiogenesis during development.
AMOT may function as an oncogene (Montrer RAB1A Anticorps) in the progression of colon cancer by activating the YAP (Montrer YAP1 Anticorps)-ERK (Montrer EPHB2 Anticorps)/PI3K (Montrer PIK3CA Anticorps)-AKT (Montrer AKT1 Anticorps) signaling pathway.
The lncRNA SNHG12 promotes cell proliferation and migration by upregulating AMOT gene expression in osteosarcoma cells in vivo and in vitro.
angiomotin and Merlin respectively interface cortical actin filaments and core kinases in Hippo signaling
Study shows miR (Montrer MLXIP Anticorps)-205 significantly downregulated and directly target the 3'-UTR (Montrer UTS2R Anticorps) of AMOT in breast cancer. In vitro, miR (Montrer MLXIP Anticorps)-205 regulates the proliferation and invasion of breast cancer cells through suppression of AMOT expression.
Amot was highly expressed in breast cancer tissues and was important in the promotion of breast cancer cell proliferation and invasion. Amot knockdown in MCF-7 cells decreased the expression of YAP (Montrer YAP1 Anticorps), YAP (Montrer YAP1 Anticorps)/TAZ (Montrer TAZ Anticorps) and LATS1 (Montrer LATS1 Anticorps).
experiments indicate that AMOT and other motin family members function together with NEDD4L (Montrer NEDD4L Anticorps) to help complete immature virion assembly prior to ESCRT-mediated virus budding
AMOT is a crucial suppressor of lung cancer metastasis and highlight its critical role as a tumor suppressor and its potential as a prognostic biomarker and therapeutic target for lung cancer.
Collectively, we have uncovered that AMOT acts as a YAP (Montrer YAP1 Anticorps) stimulator in high glucose level.
Rho attenuates the interaction between Amot and Nf2 (Montrer NF2 Anticorps) by binding to the coiled-coil domain of Amot.
TFPI-1 (Montrer TFPI Anticorps) interacts with AMOT, which led to a decrease in the phosphorylation of YAP (Montrer YAP1 Anticorps) and further increased the genes expression of the proliferation and migration involved. Our results further confirmed that atherosclerosis was a localized disease.
a new function of RNF146 (Montrer RNF146 Anticorps) and tankyrase in stabilizing the Crumbs complex through downregulation of AMOT proteins at the apical membrane, is reported.
Within the nucleus, Amot-p130 was associated with the transcriptional complex containing Yap (Montrer YAP1 Anticorps) and Teads (TEA domain family members) and contributed to the regulation of a subset of Yap (Montrer YAP1 Anticorps) target genes, many of which are associated with tumorigenesis.
The loss of Angiomotin, together with Angiomotin-like 2 (Montrer AMOTL2 Anticorps), leads to differentiation of inner cell mass cells and compromised peri (Montrer POSTN Anticorps)-implantation development.
The phosphorylation of S176 in the N-terminal domain of Amot is a critical step for activation of the Hippo pathway in adherens junctions and cell polarity disconnects the Hippo pathway from cell-cell adhesion by sequestering Amot from AJs.
Amot, Amotl1 (Montrer AMOTL1 Anticorps), and Amotl2 (Montrer AMOTL2 Anticorps) are differentially expressed in uterine cells during the peri (Montrer POSTN Anticorps)-implantation period.
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors.
This gene belongs to the motin family of angiostatin binding proteins characterized by conserved coiled-coil domains and C-terminal PDZ binding motifs. The encoded protein is expressed predominantly in endothelial cells of capillaries as well as larger vessels of the placenta where it may mediate the inhibitory effect of angiostatin on tube formation and the migration of endothelial cells toward growth factors during the formation of new blood vessels. Alternative splicing results in multiple transcript variants encoding different isoforms.
angiomotin like 2
, angiomotin-like protein 2
, angiomotin-like protein 2-like
, angiomotin p130 isoform
, angiomotin p80 isoform